Trending

glioblastoma multiforme

TAE raises $40m to develop new targeted radiotherapy

TAE raises $40m to develop new targeted radiotherapy

Medtech firm TAE Life Sciences is developing a ground-breaking radiotherapy technology which will be able to treat hard-to-reach

X

TAE raises $40m to develop new targeted radiotherapy

https://pharmaphorum.com/news/tae-raises-40m-develop-new-targeted-radiotherapy/

Kick-starting innovation in Glioblastoma

Kick-starting innovation in Glioblastoma

Can risk-sharing and real-world evidence can provide traction in treating the brain cancer Glioblastoma?

X

Kick-starting innovation in Glioblastoma

https://pharmaphorum.com/views-and-analysis/innovation-glioblastoma/

Tocagen’s brain tumour candidate gets PRIME designation

Tocagen’s brain tumour candidate gets PRIME designation

An early-stage drug candidate for hard-to-treat brain tumours has been granted special ‘PRIME’ status by the European Medicines

X

Tocagen’s brain tumour candidate gets PRIME designation

https://pharmaphorum.com/news/tocagens-brain-tumour-treatment-gets-prime-designation/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com